ARCHIVES

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Tipping Resigns Forom ACS; Vaughan Joins UAB BMT Program; PCI Recruits Ball, Finn, Mirro

September 20, 1991

DES Study Indicates Threat If Vaginal Cancer May Not Be Serious

November 15, 1974

In Brief: Krakoff moves To Scotland; Salmon Wins Waldenstrom Award; ONS endorses Reform

November 5, 1993

Cancer Centers: John Glick to step down after 21 years directing Penn’s Abramson Cancer Center.

December 2, 2005

DCT Board Approves Concepts For Three Radiation Research RFAs

March 6, 1987

Doubling Budget For NSF High Priority For FASEB.

April 20, 2001